Sacituzumab Govitecan plus Pembrolizumab in 1L Metastatic Non-Small Cell Lung Cancer: Preliminary Results of the EVOKE-02 Study
B. C. Cho,M. C. Dols,R. Reyes Cabanillas,D. Vicente Baz,J. Fuentes Pradera,S. Grisanti,A. E. Gabayan,K. H. Lee,E. K. Cho,S. Mekan,F. Safavi,N. Fernando,M. J. Chisamore,M. Reck
